Brian Yan
University of Western Ontario
37 Papers
75 Citations
Brian Yan is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 8, co-authored 37 publications. Previous affiliations of Brian Yan include London Health Sciences Centre & Stanford University.
Chat about Author
Papers
Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST)
Amindeep Sandhu,Mahmoud Mosli,Mahmoud Mosli,Mahmoud Mosli,Brian Yan,Thomas Wu,Jamie Gregor,Nilesh Chande,Terry Ponich,Melanie D. Beaton,Adam Rahman +10 more
TL;DR: Self-administered nutrition screening in outpatients with IBD is valid using the MUST screening tool and is easy to use and will increase utilization of malnutrition screening in hectic outpatient clinic settings and will help HCPs determine which patients require additional nutrition support.
65
Performance report cards increase adenoma detection rate.
TL;DR: Improvements in ADR were not correlated with specialty although gastroenterologists were 52 % more likely to find an adenoma than general surgeons, especially among physicians with low ADR.
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
Saleh Al Draiweesh,Saleh Al Draiweesh,Christopher Ma,M Alkhattabi,M Alkhattabi,Cassandra McDonald,Tran M Nguyen,Melanie D. Beaton,Nilesh Chande,Patrick H. D. Colquhoun,Brian G. Feagan,James C. Gregor,Reena Khanna,Paul Marotta,Terry Ponich,Douglas Quan,Karim Qumosani,Amindeep Sandhu,Michael Sey,Anton I. Skaro,Anouar Teriaky,Aze Wilson,Brian Yan,Mayur Brahmania,Vipul Jairath +24 more
TL;DR: Inflammatory bowel disease patients receiving combination biologic and antirejection therapy post-LT appeared to be at increased risk of Clostridium difficile and compared with the general liver transplant population in the published literature, there was no increase risk of serious infection.
15
Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
Lukasz Kwapisz,Mahmoud Mosli,Nilesh Chande,Brian Yan,Melanie D. Beaton,Jessica Micsko,Pauline W Mennill,William Barnett,Kevin Bax,Terry Ponich,John H. Howard,Anthony Tirolese,Robert Lannigan,James C. Gregor +13 more
TL;DR: Fecal rapid calprotectin testing is an accurate test when used as an initial screening tool for patients suspected of having active IBD and may prove to reduce the need for colonoscopy and be an added tool in the management of IBD.
11